OCS Competitors & Alternatives
Compare Oculis Holding AG Ordinary shares with similar stocks in the same industry
Biotechnology
OCS
Main Stock$11.39
Tradestie Score
50
Market Cap
$910.64M
Revenue Growth
-0.3%
Analyst Upside
+234.1%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$17.25
|
$718.62M | - | 58 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$28.24
|
$715.25M | - | 52 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$116.25
|
$699.30M | - | 50 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$5.85
|
$688.47M | - | 50 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.64
|
$665.30M | - | 49 | Compare |
|
ANL
ANL
|
$10.48
|
$656.86M | - | 51 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.08
|
$626.91M | - | 54 | Compare |
|
SVRA
Savara Inc.
|
$5.44
|
$611.84M | - | 60 | Compare |
More OCS Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry